Full Press Release Details
Leiden, theNetherlands, April 7, 2026:Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) today announced that its management will participate in the following investor conferences in the month of April:
25th Annual Needham Virtual Healthcare Conference, April 13, 2026Fabrice Chouraqui, Chief Executive Officer, and Anurag Relan, Chief Medical Officer, will present on Monday, April 13 at 08:45 am ET/14:45 CET. A live webcast and replay of the presentation will be available in the “Upcoming Events” and “News” sections of Pharming’s website.
Van Lanschot Kempen Life Sciences Conference 2026, Amsterdam, NL, April 15, 2026
For more information about these conferences, or to schedule a one-on-one meeting with Pharming’s management team, please contact Pharming’s Investor Relations team atinvestor@pharming.comor your Needham or Van Lanschot Kempen representative.
About Pharming Group N.V.Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. We are developing and commercializing a portfolio of innovative medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, with a significant proportion of its employees based in the U.S.
For more information, visitwww.pharming.comand find us onLinkedIn.
For further public information, contact:Investor RelationsMichael Levitan, VP Investor Relations & Corporate CommunicationsT: +1 (908) 705 1696E:investor@pharming.com
Media RelationsGlobal: Saskia Mehring, Corporate Communications ManagerT: +31 6 28 32 60 41E:media.relations@pharming.com
U.S.: Ethan Metelenis (Precision AQ on behalf of Pharming)T: +1 (917) 882-9038
Netherlands: Leon Melens (LifeSpring Life Sciences Communication on behalf of Pharming)T: +31 6 53 81 64 27
Attachment
Pharming attending Investor Conferences April 2026_EN_07APR26